Suppr超能文献

无明显药物相互作用的预防性偏头痛药物综合清单。

Comprehensive list of preventative migraine headache medications without significant drug-drug interactions.

作者信息

Dave Jay, Hakkinen Ian, Zhang Pengfei

机构信息

Department of Neurology, Mount Sinai Hospital, New York, NY, United States.

Department of Neurology, Evergreen Health, Kirkland, WA, United States.

出版信息

Front Neurol. 2024 Dec 12;15:1527897. doi: 10.3389/fneur.2024.1527897. eCollection 2024.

Abstract

BACKGROUND/OBJECTIVE: Preventive medications are crucial in migraine prevention. In cases of refractory migraine headaches, multiple medications may be required. We seek to identify a comprehensive list of preventive migraine headache medications that can be used as two, three, and four drug combinations without drug-drug interactions.

METHODS

We compiled a list of prevention medications from Szperka et al.'s "Migraine Care in the Era of COVID-19" as well as American Headache Society's 2018 and 2021 "Consensus Statements on Integrating New Migraine Treatments into Clinical Practice." We obtained all possible two to four combinations of prevention medications through this list. We then filtered out all combinations containing at least one interaction based on DrugBank database and also identified least to most interacting medications.

RESULTS

A total of 26 unique prevention medications are identified. This results in a total of 325 combinations of two preventives, 2,600 combinations of three preventives, and 14,950 combinations of four preventives. There are a total of 124, 146, and 0 non-interacting two, three, and four preventive combinations, respectively. All except 16 combinations of pick-twos can be placed within a pick-three combinations. The resulting distinct non-interacting medications can be represented by a condensed list of 162 unique combinations of medications. CGRP antagonists, Botulinum toxin A, melatonin, and candesartan are least interacting.

CONCLUSION

This list of migraine preventive medications without drug-drug interactions is a useful tool for clinicians seeking to manage refractory headaches more effectively by implementing an evidence-based polypharmacy.

摘要

背景/目的:预防性药物在偏头痛预防中至关重要。对于难治性偏头痛病例,可能需要多种药物。我们试图确定一份全面的预防性偏头痛药物清单,这些药物可以作为两种、三种和四种药物组合使用,且不存在药物相互作用。

方法

我们从斯佩尔卡等人的《COVID-19时代的偏头痛护理》以及美国头痛协会2018年和2021年的《关于将新的偏头痛治疗方法纳入临床实践的共识声明》中编制了一份预防药物清单。通过这份清单,我们获得了所有可能的两种至四种预防药物组合。然后,我们根据药物银行数据库筛选出所有包含至少一种相互作用的组合,并确定了相互作用最少到最多的药物。

结果

共确定了26种独特的预防药物。这导致共有325种两种预防药物的组合、2600种三种预防药物的组合和14950种四种预防药物的组合。分别有124种、146种和0种无相互作用的两种、三种和四种预防药物组合。除了16种两种药物组合外,所有组合都可以包含在三种药物组合中。由此产生的独特无相互作用药物组合可以由一份包含162种独特药物组合的精简清单表示。降钙素基因相关肽(CGRP)拮抗剂、肉毒杆菌毒素A、褪黑素和坎地沙坦的相互作用最少。

结论

这份无药物相互作用的偏头痛预防药物清单是一个有用的工具,可供临床医生通过实施循证多药联合治疗更有效地管理难治性头痛。

相似文献

本文引用的文献

8
Combination therapy in migraine: asset or issue?偏头痛的联合治疗:是优势还是问题?
Expert Rev Neurother. 2020 Oct;20(10):995-996. doi: 10.1080/14737175.2020.1821655. Epub 2020 Sep 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验